Alnylam Pharmaceuticals Inc
Sector:
Industry:
144.315
-0.845
(-0.582%)
Volume:
702,519
52 week range:
143.47 - 218.88
Market Cap:
18.176B
Company Description:
alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.